VIATRIS INC. Operating Expenses
VIATRIS INC. (VTRS) reported Operating Expenses of $1.45 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-06
- VIATRIS INC. operating expenses for the quarter ending 2026-06-30 was $1.45B, a 31.85% increase year-over-year.
- VIATRIS INC. operating expenses for the quarter ending 2026-03-31 was $1.24B, a 69.41% decline year-over-year.
- VIATRIS INC. operating expenses for the quarter ending 2025-12-31 was $1.34B, a 3.89% decline year-over-year.
- VIATRIS INC. operating expenses for the quarter ending 2025-09-30 was $1.19B, a 3.29% decline year-over-year.
- VIATRIS INC. operating expenses for fiscal 2025 was $7.68B, a 36.75% increase from fiscal 2024.
- VIATRIS INC. operating expenses for fiscal 2024 was $5.61B, a 1.04% decline from fiscal 2023.
- VIATRIS INC. operating expenses for fiscal 2023 was $5.67B, a 16.19% increase from fiscal 2022.
- VIATRIS INC. operating expenses for fiscal 2022 was $4.88B, a 12.97% decline from fiscal 2021.
| Period end | Operating Expenses 1 month | Operating Expenses 3 month | Operating Expenses 4 month | Operating Expenses 6 month | Operating Expenses 7 month | Operating Expenses 9 month | Operating Expenses 11 month | Operating Expenses 12 month |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.45B 10-Q · filed 2026-08-06 | $2.69B 10-Q · filed 2026-08-06 | $4.03B derived: sum of 3 quarters · filed 2026-08-06 | $5.22B derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $1.24B 10-Q · filed 2026-05-07 | $2.58B derived: sum of 2 quarters · filed 2026-05-07 | $3.77B derived: sum of 3 quarters · filed 2026-05-07 | $4.87B derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $1.34B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.53B derived: sum of 2 quarters · filed 2026-02-26 | $3.63B derived: sum of 3 quarters · filed 2026-08-06 | $7.68B 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $1.19B 10-Q · filed 2025-11-06 | $2.29B derived: sum of 2 quarters · filed 2026-08-06 | $6.34B 10-Q · filed 2025-11-06 | $7.73B derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $1.10B 10-Q · filed 2026-08-06 | $5.14B 10-Q · filed 2026-08-06 | $6.54B derived: sum of 3 quarters · filed 2026-08-06 | $7.77B derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $4.04B 10-Q · filed 2026-05-07 | $5.44B derived: sum of 2 quarters · filed 2026-05-07 | $6.67B derived: sum of 3 quarters · filed 2026-05-07 | $8.36B derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $1.39B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.63B derived: sum of 2 quarters · filed 2026-02-26 | $4.31B derived: sum of 3 quarters · filed 2026-02-26 | $5.61B 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $1.23B 10-Q · filed 2025-11-06 | $2.92B derived: sum of 2 quarters · filed 2025-11-06 | $4.22B 10-Q · filed 2025-11-06 | $6.27B derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $1.69B 10-Q · filed 2025-08-07 | $2.99B 10-Q · filed 2025-08-07 | $5.04B derived: sum of 3 quarters · filed 2026-02-26 | $6.28B derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $1.30B 10-Q · filed 2025-05-08 | $3.35B derived: sum of 2 quarters · filed 2026-02-26 | $4.59B derived: sum of 3 quarters · filed 2026-02-26 | $5.83B derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $2.05B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.29B derived: sum of 2 quarters · filed 2026-02-26 | $4.53B derived: sum of 3 quarters · filed 2026-02-26 | $5.67B 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $1.24B 10-Q · filed 2024-11-07 | $2.48B derived: sum of 2 quarters · filed 2024-11-07 | $3.62B 10-Q · filed 2024-11-07 | $5.10B derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-06-30 | $1.24B 10-Q · filed 2024-08-08 | $2.38B 10-Q · filed 2024-08-08 | $3.86B derived: sum of 3 quarters · filed 2025-02-27 | $5.05B derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-03-31 | $1.14B 10-Q · filed 2024-05-09 | $2.62B derived: sum of 2 quarters · filed 2025-02-27 | $3.81B derived: sum of 3 quarters · filed 2025-02-27 | $4.96B derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2022-12-31 | $1.48B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $2.66B derived: sum of 2 quarters · filed 2025-02-27 | $3.82B derived: sum of 3 quarters · filed 2025-02-27 | $4.88B 10-K · filed 2025-02-27 | ||||
| 2022-09-30 | $1.19B 10-Q · filed 2023-11-08 | $2.34B derived: sum of 2 quarters · filed 2023-11-08 | $3.41B 10-Q · filed 2023-11-08 | $5.03B derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-06-30 | $1.15B 10-Q · filed 2023-08-07 | $2.22B 10-Q · filed 2023-08-07 | $3.84B derived: sum of 3 quarters · filed 2024-02-28 | $5.06B derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-03-31 | $1.06B 10-Q · filed 2023-05-08 | $2.69B derived: sum of 2 quarters · filed 2024-02-28 | $3.90B derived: sum of 3 quarters · filed 2024-02-28 | $5.28B derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2021-12-31 | $1.62B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $2.84B derived: sum of 2 quarters · filed 2024-02-28 | $4.22B derived: sum of 3 quarters · filed 2024-02-28 | $5.61B 10-K · filed 2024-02-28 | ||||
| 2021-09-30 | $1.22B 10-Q · filed 2022-11-07 | $2.59B derived: sum of 2 quarters · filed 2022-11-07 | $3.99B 10-Q · filed 2022-11-07 | $5.57B derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-06-30 | $1.38B 10-Q · filed 2022-08-08 | $2.77B 10-Q · filed 2022-08-08 | $4.36B derived: sum of 3 quarters · filed 2023-02-27 | $5.16B derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-03-31 | $1.39B 10-Q · filed 2022-05-09 | $2.98B derived: sum of 2 quarters · filed 2023-02-27 | $3.79B derived: sum of 3 quarters · filed 2023-02-27 | |||||
| 2020-12-31 | $1.59B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $2.39B derived: sum of 2 quarters · filed 2023-02-27 | $4.01B 10-K · filed 2023-02-27 | |||||
| 2020-09-30 | $807.10M 10-Q · filed 2021-11-08 | $2.42B 10-Q · filed 2021-11-08 | ||||||
| 2020-09-27 | $0.00 10-Q · filed 2020-11-10 | $891.50M derived: sum of 2 quarters · filed 2021-08-09 | $0.00 10-Q · filed 2020-11-10 | |||||
| 2020-06-30 | $891.50M 10-Q · filed 2021-08-09 | $1.61B 10-Q · filed 2021-08-09 | ||||||
| 2020-06-28 | $0.00 10-Q · filed 2020-08-12 | $0.00 10-Q · filed 2020-08-12 | ||||||
| 2020-03-31 | $721.40M 10-Q · filed 2021-05-10 | |||||||
| 2020-03-29 | $0.00 10-Q · filed 2020-05-12 | |||||||
| 2019-12-31 | $0.00 10-K · filed 2020-05-07 | $3.18B 10-K · filed 2022-02-28 | ||||||
| 2019-09-29 | $0.00 10-Q · filed 2020-11-10 | $0.00 derived: sum of 2 quarters · filed 2020-11-10 | $0.00 10-Q · filed 2020-11-10 | |||||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-12 | $0.00 10-Q · filed 2020-08-12 | ||||||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-12 | |||||||
| 2018-12-31 | $3.10B 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |